Introduction to Respiratory Syncytial Virus (RSV) in Children

Respiratory Syncytial Virus (RSV) is the leading cause of lower respiratory tract infections in infants and young children worldwide. Nearly all children will have been infected with RSV by the age of two, and although most infections result in mild cold-like symptoms, RSV is also responsible for a significant number of hospitalizations each year. In the United States alone, RSV leads to an estimated 58,000 to 80,000 hospitalizations among children under five, with infants under six months at the greatest risk for severe disease. Understanding how to prevent and manage RSV infections is essential for parents, caregivers, and healthcare providers. This comprehensive guide covers everything from transmission and prevention to symptom recognition, home management, and when to seek emergency care.

Understanding RSV and Its Impact on Children

How RSV Spreads

RSV is a highly contagious virus that spreads primarily through respiratory droplets when an infected person coughs or sneezes. The virus can also survive on hard surfaces—such as countertops, toys, and doorknobs—for several hours, making indirect contact a significant route of transmission. Additionally, RSV can be passed through direct contact, such as kissing or touching an infected child, or through contaminated hands. The incubation period ranges from 4 to 6 days, and infected individuals are typically contagious for 3 to 8 days, though young infants and immunocompromised children may shed the virus for longer periods.

Seasonality and At-Risk Populations

In temperate climates, RSV outbreaks typically occur during the fall, winter, and early spring, with peak activity in December and January. However, seasonal patterns can vary by region. While most children who contract RSV experience mild illness, certain groups face a higher risk of severe disease. These include:

  • Premature infants (especially those born before 29 weeks gestational age)
  • Children under 6 months old
  • Children with chronic lung disease of prematurity (bronchopulmonary dysplasia)
  • Children with congenital heart disease, particularly those with hemodynamically significant lesions
  • Children with compromised immune systems (due to transplant, chemotherapy, or primary immunodeficiency)
  • Children with neuromuscular disorders that impair airway clearance

Short- and Long-Term Consequences

Severe RSV infection in infancy has been linked to long-term respiratory issues. Studies have shown that children hospitalized with RSV bronchiolitis are more likely to develop recurrent wheezing and asthma later in childhood. The exact mechanism is still under investigation, but it is believed that the inflammation caused by the virus can lead to airway remodeling and heightened airway reactivity. This makes prevention and early, effective management even more critical to reduce both acute morbidity and potential chronic sequelae.

Prevention Strategies: How to Reduce the Risk of RSV Infection

Preventing RSV infection requires a multi-layered approach that combines good hygiene practices, environmental cleaning, social distancing, and—for high-risk infants—the use of passive immunization. No vaccine is currently approved for active immunization of infants, but recent advances in maternal RSV vaccines and monoclonal antibody therapies offer new hope for prevention.

Hand Hygiene and Respiratory Etiquette

Frequent and thorough handwashing is one of the most effective ways to prevent the spread of RSV. Parents and caregivers should wash their hands with soap and water for at least 20 seconds before handling a baby, after using the bathroom, and after being in public spaces. If soap and water are not available, an alcohol-based hand sanitizer containing at least 60% alcohol can be used. Older children should be taught to cover their coughs and sneezes with a tissue or their elbow, and to avoid touching their eyes, nose, and mouth.

Environmental Cleaning and Disinfection

Since RSV can survive on surfaces for up to 6 to 8 hours, regular cleaning and disinfection of high-touch surfaces is crucial. Focus on:

  • Toys, pacifiers, and feeding utensils
  • Doorknobs, light switches, and remote controls
  • Countertops, tables, and bathroom fixtures
  • Cell phones and tablets (use a disinfectant wipe safe for electronics)

A solution of bleach diluted with water (1 tablespoon bleach per quart of water) is an effective disinfectant, but many commercial household disinfectants also kill RSV. Always follow the manufacturer’s instructions for contact time and safety.

Limiting Exposure During RSV Season

Avoid crowded places such as shopping malls, public transportation, and daycare centers, especially during peak RSV season. If you have a newborn or a high-risk infant, consider limiting visitors and asking family members to wash their hands and wear a mask if they have any respiratory symptoms. Siblings who attend school or daycare should be reminded to practice good hygiene and avoid sharing cups or utensils.

Breastfeeding and Nutritional Support

Breastfeeding provides infants with antibodies that may help reduce the severity of RSV infection. While it does not completely prevent infection, exclusive breastfeeding for the first 6 months has been associated with lower rates of hospitalization and a reduced risk of severe respiratory illness. For formula-fed infants, proper bottle hygiene is important to avoid introducing other pathogens that could complicate the illness.

Passive Immunization: Palivizumab and Nirsevimab

For infants at high risk of severe RSV, a monoclonal antibody called palivizumab (Synagis) has been available for decades. It is administered as a monthly injection during RSV season and can reduce the incidence of hospitalization by about 50% in high-risk groups. However, it is not recommended for healthy full-term infants due to cost and the burden of monthly injections.

A newer and more effective option, nirsevimab (Beyfortus), was approved in 2023. It offers protection with a single dose given before or during RSV season and has shown 70–80% efficacy in preventing RSV-related hospitalizations in healthy late-preterm and full-term infants. The American Academy of Pediatrics (AAP) now recommends nirsevimab for all infants under 8 months entering their first RSV season, as well as for high-risk children aged 8 to 19 months entering their second season. Additionally, a maternal RSV vaccine (Abrysvo) has been approved for women in their third trimester of pregnancy, providing passive immunity to the newborn in the first months of life. This is a major advance in preventing severe disease in very young infants.

Recognizing the Symptoms of RSV

Early symptoms of RSV infection usually appear 4 to 6 days after exposure and often mimic a common cold. However, as the virus progresses deeper into the lower airways, more concerning signs may develop. It is useful to think of the illness in stages:

Mild Stage (Upper Respiratory Symptoms)

  • Runny nose (clear discharge, later may become thicker)
  • Nasal congestion
  • Mild cough
  • Low-grade fever (often under 101°F / 38.3°C)
  • Decreased appetite
  • Sneezing

Moderate to Severe Stage (Lower Respiratory Involvement)

  • Worsening cough, often becoming persistent and paroxysmal
  • Wheezing (a high-pitched sound when exhaling)
  • Rapid breathing (tachypnea) – more than 60 breaths per minute in newborns
  • Retractions – chest wall pulling in with each breath (seen between ribs, at the collarbone, or below the ribcage)
  • Nasal flaring – widening of the nostrils during breathing
  • Difficulty feeding due to shortness of breath
  • Grunting or head bobbing (signs of respiratory distress in infants)
  • Apnea (pauses in breathing) – this is especially dangerous in premature infants and those under 2 months of age

It is important to note that fever may not be prominent in very young infants. Parents should be alert to any change in breathing or feeding behavior, as these are often the first clues that the infection is becoming serious.

Managing RSV Infections at Home

Most children with RSV can be managed at home with supportive care. Antibiotics are ineffective against viruses, and antiviral medications are not routinely used for RSV in otherwise healthy children. The goal of home management is to relieve symptoms, maintain hydration, and monitor for any deterioration that requires medical attention.

Hydration and Nutritional Support

Maintaining adequate fluid intake is crucial. Infants who are breastfeeding or bottle-feeding should be offered smaller, more frequent feeds to prevent fatigue. If nasal congestion makes sucking difficult, use a bulb syringe or nasal aspirator to clear the nose before feeding. For older children, offer clear liquids such as water, broth, or electrolyte solutions (e.g., Pedialyte). Signs of dehydration include dry mouth and lips, no tears when crying, sunken fontanelles (soft spots on the head), and fewer wet diapers (less than 6 per day in infants). If dehydration is suspected, contact your pediatrician immediately.

Airway Clearance and Breathing Comfort

Nasal congestion is often the most distressing symptom for infants. Using saline nose drops followed by gentle suction with a bulb syringe or a battery-powered nasal aspirator can help clear mucus and make breathing easier. This is especially important before feedings and sleep. Additionally, using a cool-mist humidifier in the child's room can add moisture to the air and soothe irritated airways. Elevating the head of the bed slightly (by placing a towel or pillow under the mattress, not directly under the infant) may help reduce nighttime coughing. Do not use pillows or soft bedding for infants under 12 months due to the risk of SIDS.

Fever and Discomfort Management

If your child has a fever and is uncomfortable, you can use over-the-counter medications as directed by your pediatrician. Acetaminophen (Tylenol) is safe for infants over 3 months (dosed by weight). Ibuprofen (Motrin, Advil) is approved for children 6 months and older. Never give aspirin to children, as it can cause Reye’s syndrome. Do not give cough and cold medications containing multiple ingredients to children under 6 years old, as they are ineffective and can have side effects. Honey (for children over 1 year) may help soothe a cough but should never be given to infants under 12 months due to the risk of infant botulism.

Rest and Activity

Allow your child to rest as much as possible. Keep the environment calm and quiet. While sleep may be disrupted by coughing, any additional rest helps the immune system fight the virus. It is okay to let an older child play quietly if they feel up to it, but avoid vigorous activity that could worsen breathing.

What Not to Do

  • Do not use steam or hot vaporizers – they can cause burns.
  • Do not use over-the-counter bronchodilators (like albuterol) unless prescribed by a doctor; they are generally not effective for RSV bronchiolitis in infants.
  • Do not give chest rubs containing camphor or menthol to infants under 2 years old, as they can cause respiratory distress.
  • Do not use antibiotic medications unless a bacterial co-infection is diagnosed.

When to Seek Medical Care

It is essential to know when home care is no longer sufficient. The following signs indicate that your child needs immediate evaluation by a healthcare professional. If any of these are present, do not wait—seek emergency care or call 911.

  • Difficulty breathing: You notice fast breathing (tachypnea), severe chest retractions, nasal flaring, or grunting with each breath.
  • Wheezing: The child has persistent wheezing that does not improve with gentle suction or albuterol (if prescribed).
  • Bluish discoloration: The lips, tongue, or nail beds turn blue or gray (cyanosis) – this is a sign of low blood oxygen.
  • Apnea: The child stops breathing for more than 15–20 seconds, or experiences any pause in breathing that causes them to turn pale or blue.
  • Dehydration: The child is not drinking enough fluids, has a dry mouth, no tears when crying, or has significantly fewer wet diapers than normal (less than 3 wet diapers in 24 hours for older infants, or less than 6 for younger ones).
  • Lethargy or unresponsiveness: The child is unusually sleepy, difficult to wake, or does not interact normally.
  • Poor feeding: The infant is taking less than half of their usual amount during feedings, especially if this lasts for more than 12 hours.
  • Fever in young infants: Any fever of 100.4°F (38°C) or higher in a baby under 3 months of age warrants immediate medical evaluation.

Medical Treatments for Severe RSV (Hospitalization)

Approximately 2–3% of children diagnosed with RSV will require hospitalization. In the hospital, treatment focuses on supportive care and close monitoring. The following interventions may be used:

  • Supplemental oxygen: Administered via nasal cannula or a high-flow nasal cannula if oxygen levels drop below 90%.
  • Nasal suctioning: Performed by nurses to clear thick mucus, especially before feedings and sleep.
  • Intravenous (IV) fluids: Given through a small tube inserted into a vein to prevent or treat dehydration, allowing the child to rest without the exertion of feeding.
  • Medications: Inhaled bronchodilators (such as albuterol) are sometimes tried, but studies show they are often ineffective for RSV bronchiolitis. Steroids are not recommended for routine use. Severe cases may require nebulized epinephrine, though evidence is mixed.
  • Mechanical ventilation: In the most severe situations when a child cannot maintain adequate breathing on their own, a breathing tube and ventilator may be needed. This is uncommon but lifesaving.

Hospital stays typically last from 2 to 7 days, depending on the severity. Most children recover fully, but those with underlying conditions may require longer stays and closer follow-up after discharge.

Long-Term Outcomes and Follow-Up Care

After recovering from a severe RSV infection, some children may experience ongoing respiratory symptoms. It is not uncommon for children to have a persistent cough for several weeks after the acute infection resolves. Additionally, there is a well-documented association between severe RSV bronchiolitis in infancy and the subsequent development of recurrent wheezing and asthma. A large study published in the New England Journal of Medicine found that children hospitalized with RSV before age 1 had a significantly higher risk of asthma diagnosis by age 6. For this reason, pediatricians often recommend close monitoring of lung function and early treatment of any wheezing episodes. Some children may benefit from referral to a pediatric pulmonologist or allergist for ongoing management.

Parents should be reassured that the risk of long-term complications can be minimized with good follow-up care and prompt treatment of respiratory symptoms. As new preventive strategies like nirsevimab and maternal vaccines become more widely adopted, the incidence of severe RSV and its long-term effects may decrease substantially in the coming years.

Conclusion: Staying Ahead of RSV

Respiratory Syncytial Virus remains a major health threat to young children, but we now have more tools than ever to prevent severe disease. Rigorous hygiene practices, thoughtful avoidance of high-risk exposures, and the use of passive immunization for eligible infants can dramatically reduce the chance of hospitalization. When infection does occur, early recognition of symptoms and appropriate home care—coupled with a clear plan for when to seek medical help—can make the difference between a mild illness and a life-threatening emergency. Parents and caregivers are encouraged to have an open discussion with their pediatrician about RSV prevention, especially before the fall season begins. For the most current recommendations, consult resources such as the Centers for Disease Control and Prevention (CDC), the American Academy of Pediatrics (AAP), and the National Institute of Allergy and Infectious Diseases.